modified kinetic rate jaffe method creatinin-jk Search Results


90
Siemens AG jaffe creatinine method
Jaffe Creatinine Method, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+kinetic+rate+jaffe+method+creatinin-jk/jaffe+creatinine+method/pmc08258456__mmc1-24-10-10
Average 90 stars, based on 1 article reviews
jaffe creatinine method - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Siemens AG dimension xpand plus hm clinical analyzer
Dimension Xpand Plus Hm Clinical Analyzer, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+kinetic+rate+jaffe+method+creatinin-jk/dimension+xpand+plus+integrated+chemistry+system/pmc04520172-306-17-16
Average 90 stars, based on 1 article reviews
dimension xpand plus hm clinical analyzer - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
BioClin Therapeutics creatinina-k0106
Creatinina K0106, supplied by BioClin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+kinetic+rate+jaffe+method+creatinin-jk/creatinina+k0106/pmc03867701-73-0-2
Average 90 stars, based on 1 article reviews
creatinina-k0106 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

96
Randox jaffé method
Jaffé Method, supplied by Randox, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+kinetic+rate+jaffe+method+creatinin-jk/CREATININE/pm24093454-74-9-12
Average 96 stars, based on 1 article reviews
jaffé method - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

90
Technik Eberhard Lehmann cr0121, creatinin, jaffé
Cr0121, Creatinin, Jaffé, supplied by Technik Eberhard Lehmann, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+kinetic+rate+jaffe+method+creatinin-jk/cr0121++creatinin++jaff%C3%A9/pm26792062-120-8-11
Average 90 stars, based on 1 article reviews
cr0121, creatinin, jaffé - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Siemens AG advia 2400 jaffe creatinine assay
Advia 2400 Jaffe Creatinine Assay, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+kinetic+rate+jaffe+method+creatinin-jk/serum+creatinine+measured+using+siemens+advia+2400+chemistry+system/pmc04619033-53-9-14
Average 90 stars, based on 1 article reviews
advia 2400 jaffe creatinine assay - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
SPINREACT SA creatinine modified jaffe method
Creatinine Modified Jaffe Method, supplied by SPINREACT SA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+kinetic+rate+jaffe+method+creatinin-jk/creatinine+++jaffe++single+reagent+/10__12681_slash_jhvms__29043-68-15-23
Average 90 stars, based on 1 article reviews
creatinine modified jaffe method - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Arbor Assays detectx® urinary creatinine detection kit
Detectx® Urinary Creatinine Detection Kit, supplied by Arbor Assays, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+kinetic+rate+jaffe+method+creatinin-jk/detect+x+serum+creatinine+detection+kit/pm32863061-107-19-24
Average 90 stars, based on 1 article reviews
detectx® urinary creatinine detection kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
BioAssay Systems LLC quantichromtm creatinine assay kit
Quantichromtm Creatinine Assay Kit, supplied by BioAssay Systems LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+kinetic+rate+jaffe+method+creatinin-jk/quantichrom+creatinine+assay+kit/pmc03777822-132-9-13
Average 90 stars, based on 1 article reviews
quantichromtm creatinine assay kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
BioAssay Systems LLC improved jaffe creatinine assay kit bioassay systems
Improved Jaffe Creatinine Assay Kit Bioassay Systems, supplied by BioAssay Systems LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+kinetic+rate+jaffe+method+creatinin-jk/improved+jaffe+creatinine+assay+kit/10__1097_slash_fjc__0b013e318168d120-51-13-17
Average 90 stars, based on 1 article reviews
improved jaffe creatinine assay kit bioassay systems - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Exocell Inc alkaline picrate colorimetry based on jaffe reaction the creatinine companion
Alkaline Picrate Colorimetry Based On Jaffe Reaction The Creatinine Companion, supplied by Exocell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+kinetic+rate+jaffe+method+creatinin-jk/alkaline+picrate+assay+creatinine+companion/pm27585521-46-12-17
Average 90 stars, based on 1 article reviews
alkaline picrate colorimetry based on jaffe reaction the creatinine companion - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Exocell Inc jaffe’ reaction of alkaline picrate with creatinine
Schematic of experimental design. Female C57Bl6/J mice were fed a normal protein diet (NPD; n = 8) or a low protein diet (LPD; n = 8) from 3 weeks prior to mating and up to weaning at P21. One male and one female offspring per litter was euthanized at P21 (weaning) for assessment of glomerular and podocyte indices. Two male and two female offspring per litter were weaned onto standard laboratory chow. At 6 weeks of age, one male and one female per litter were administered i.p. injections of streptozotocin (55 mg/kg) to induce diabetes or citrate buffer (control); daily over 5 days. P, protein; F, fat; STZ, streptozotocin; CB, citrate buffer; ACR, albumin <t>creatinine</t> ratio; GSI, glomerulosclerotic index; BGL, blood glucose level; 6 W, 6 weeks of age; 24 W, 24 weeks of age.
Jaffe’ Reaction Of Alkaline Picrate With Creatinine, supplied by Exocell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+kinetic+rate+jaffe+method+creatinin-jk/jaffe%E2%80%99+reaction+of+alkaline+picrate+with+creatinine/pmc09875819-103-8-12
Average 90 stars, based on 1 article reviews
jaffe’ reaction of alkaline picrate with creatinine - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Schematic of experimental design. Female C57Bl6/J mice were fed a normal protein diet (NPD; n = 8) or a low protein diet (LPD; n = 8) from 3 weeks prior to mating and up to weaning at P21. One male and one female offspring per litter was euthanized at P21 (weaning) for assessment of glomerular and podocyte indices. Two male and two female offspring per litter were weaned onto standard laboratory chow. At 6 weeks of age, one male and one female per litter were administered i.p. injections of streptozotocin (55 mg/kg) to induce diabetes or citrate buffer (control); daily over 5 days. P, protein; F, fat; STZ, streptozotocin; CB, citrate buffer; ACR, albumin creatinine ratio; GSI, glomerulosclerotic index; BGL, blood glucose level; 6 W, 6 weeks of age; 24 W, 24 weeks of age.

Journal: Physiological Reports

Article Title: Nephron deficit and low podocyte density increase risk of albuminuria and glomerulosclerosis in a model of diabetes

doi: 10.14814/phy2.15579

Figure Lengend Snippet: Schematic of experimental design. Female C57Bl6/J mice were fed a normal protein diet (NPD; n = 8) or a low protein diet (LPD; n = 8) from 3 weeks prior to mating and up to weaning at P21. One male and one female offspring per litter was euthanized at P21 (weaning) for assessment of glomerular and podocyte indices. Two male and two female offspring per litter were weaned onto standard laboratory chow. At 6 weeks of age, one male and one female per litter were administered i.p. injections of streptozotocin (55 mg/kg) to induce diabetes or citrate buffer (control); daily over 5 days. P, protein; F, fat; STZ, streptozotocin; CB, citrate buffer; ACR, albumin creatinine ratio; GSI, glomerulosclerotic index; BGL, blood glucose level; 6 W, 6 weeks of age; 24 W, 24 weeks of age.

Article Snippet: Creatinine was measured using the Jaffe’ reaction of alkaline picrate with creatinine (Exocell).

Techniques: Control

LPD induces growth restriction, low nephron endowment, and low podocyte endowment at weaning, but normal kidney function and histology at 24 weeks of age. (a) Pre‐weaning bodyweight (P2‐21); data analyzed by repeated measures 3‐way ANOVA for diet, sex, and time; no sex difference identified so data were consolidated and analyzed by 2‐way ANOVA for diet and time. (b) Total kidney weight (left and right kidney combined), (c) total glomerular number per kidney and (d) glomerular number per gram of bodyweight at P21; data analyzed by 2‐way ANOVA for diet and sex, no sex difference identified (e) glomerular volume, (f) podocyte number per glomerulus, and G) podocyte density at P21 and 24 weeks of age; data analyzed by three‐way ANOVA for diet, sex, and time, no sex difference identified so data were consolidated and analyzed by 2‐way ANOVA for diet and time. (h, i) Bodyweight from P21 to 24 weeks of age in male (h) and female (i) offspring; presented separately to show the identified sex difference following repeated measures 3‐way ANOVA for diet, sex, and time. (j) Left kidney weight and (k) albumin: creatinine area under the curve at 24 weeks in male and female offspring indicating the sex difference identified following 2‐way ANOVA for diet and sex. (l) glomerulosclerotic index in NPD and LPD offspring at 24 weeks of age; data analyzed by 2‐way ANOVA for diet and sex, no sex difference identified. NPD (white circles), LPD (black circles). Asterisks above data points represent significant differences between NPD and LPD; asterisks below datapoints represent significant differences between P21 and 24 weeks. In all cases, values are mean ± SD. where * p < 0.05, ** p < 0.01, *** p < 0.001 and **** p < 0.0001 following multiple comparisons. P, postnatal day; 24 W, 24 weeks.

Journal: Physiological Reports

Article Title: Nephron deficit and low podocyte density increase risk of albuminuria and glomerulosclerosis in a model of diabetes

doi: 10.14814/phy2.15579

Figure Lengend Snippet: LPD induces growth restriction, low nephron endowment, and low podocyte endowment at weaning, but normal kidney function and histology at 24 weeks of age. (a) Pre‐weaning bodyweight (P2‐21); data analyzed by repeated measures 3‐way ANOVA for diet, sex, and time; no sex difference identified so data were consolidated and analyzed by 2‐way ANOVA for diet and time. (b) Total kidney weight (left and right kidney combined), (c) total glomerular number per kidney and (d) glomerular number per gram of bodyweight at P21; data analyzed by 2‐way ANOVA for diet and sex, no sex difference identified (e) glomerular volume, (f) podocyte number per glomerulus, and G) podocyte density at P21 and 24 weeks of age; data analyzed by three‐way ANOVA for diet, sex, and time, no sex difference identified so data were consolidated and analyzed by 2‐way ANOVA for diet and time. (h, i) Bodyweight from P21 to 24 weeks of age in male (h) and female (i) offspring; presented separately to show the identified sex difference following repeated measures 3‐way ANOVA for diet, sex, and time. (j) Left kidney weight and (k) albumin: creatinine area under the curve at 24 weeks in male and female offspring indicating the sex difference identified following 2‐way ANOVA for diet and sex. (l) glomerulosclerotic index in NPD and LPD offspring at 24 weeks of age; data analyzed by 2‐way ANOVA for diet and sex, no sex difference identified. NPD (white circles), LPD (black circles). Asterisks above data points represent significant differences between NPD and LPD; asterisks below datapoints represent significant differences between P21 and 24 weeks. In all cases, values are mean ± SD. where * p < 0.05, ** p < 0.01, *** p < 0.001 and **** p < 0.0001 following multiple comparisons. P, postnatal day; 24 W, 24 weeks.

Article Snippet: Creatinine was measured using the Jaffe’ reaction of alkaline picrate with creatinine (Exocell).

Techniques:

Disease susceptibility following induction of diabetes. (a) Blood glucose level presented as area under the curve (AUC) (analyzed by 3‐way ANOVA for diet, sex, and treatment) showing the significant difference between males and females. Blood glucose in male (b) and female (c) offspring across the 18‐week experimental period analyzed by 3‐way ANOVA with repeated measures for diet, treatment, and time. (d) kidney weight at 24 weeks following 18 weeks of hyperglycemia; analyzed by three‐way ANOVA for diet, sex, and treatment. Values are mean ± SD, where ** p < 0.01, *** p < 0.001, **** p < 0.0001 following multiple comparisons, differences between sexes not shown. c, control (citrate buffer); d, diabetic (STZ treatment). (e) Podocyte number per glomerulus, (f) glomerular volume, (g) podocyte density, and (h) albumin: creatinine area under the curve, in control and diabetic NPD and LPD offspring. Each dataset in e–h analyzed by three‐way ANOVA for diet, sex, and treatment. No sex difference was identified, data were consolidated and analyzed by 2‐way ANOVA for diet and treatment; in all cases values are mean ± SD, where * p < 0.05, *** p < 0.001 and **** p < 0.0001 following multiple comparisons. (i) Albumin: creatinine across the experimental period; no sex difference identified in ACR AUC, so ACR analyzed by repeated measures 3‐way ANOVA for diet, treatment, and time where * p < 0.05 between LPD control and LPD diabetic, *** p < 0.001 between LPD control and LPD diabetic, **** p < 0.0001 between LPD control and LPD diabetic, ^^^ p < 0.001 between NPD control and NPD diabetic, ^^^^ p < 0.0001 between NPD control and NPD diabetic, ## p < 0.01 between NPD diabetic and LPD diabetic offspring. (j) Glomerulosclerotic index at 24 weeks of age in control and diabetic NPD and LPD offspring, data analyzed by three‐way ANOVA for diet, sex, and treatment, no sex difference was identified, data were consolidated and analyzed by 2‐way ANOVA for diet and treatment with values presented as mean ± SD, where *** p < 0.001 and **** p < 0.0001 following multiple comparisons. (k) Linear regression of the relationship between podocyte density and glomerulosclerotic index at 24 weeks of age (18 weeks of hyperglycemia in diabetic animals). In a–k: NPD—control (white circles), LPD—control (black circles), NPD—diabetic (white squares), LPD—diabetic (black squares). C, control; d, diabetic; M, male; f, female.

Journal: Physiological Reports

Article Title: Nephron deficit and low podocyte density increase risk of albuminuria and glomerulosclerosis in a model of diabetes

doi: 10.14814/phy2.15579

Figure Lengend Snippet: Disease susceptibility following induction of diabetes. (a) Blood glucose level presented as area under the curve (AUC) (analyzed by 3‐way ANOVA for diet, sex, and treatment) showing the significant difference between males and females. Blood glucose in male (b) and female (c) offspring across the 18‐week experimental period analyzed by 3‐way ANOVA with repeated measures for diet, treatment, and time. (d) kidney weight at 24 weeks following 18 weeks of hyperglycemia; analyzed by three‐way ANOVA for diet, sex, and treatment. Values are mean ± SD, where ** p < 0.01, *** p < 0.001, **** p < 0.0001 following multiple comparisons, differences between sexes not shown. c, control (citrate buffer); d, diabetic (STZ treatment). (e) Podocyte number per glomerulus, (f) glomerular volume, (g) podocyte density, and (h) albumin: creatinine area under the curve, in control and diabetic NPD and LPD offspring. Each dataset in e–h analyzed by three‐way ANOVA for diet, sex, and treatment. No sex difference was identified, data were consolidated and analyzed by 2‐way ANOVA for diet and treatment; in all cases values are mean ± SD, where * p < 0.05, *** p < 0.001 and **** p < 0.0001 following multiple comparisons. (i) Albumin: creatinine across the experimental period; no sex difference identified in ACR AUC, so ACR analyzed by repeated measures 3‐way ANOVA for diet, treatment, and time where * p < 0.05 between LPD control and LPD diabetic, *** p < 0.001 between LPD control and LPD diabetic, **** p < 0.0001 between LPD control and LPD diabetic, ^^^ p < 0.001 between NPD control and NPD diabetic, ^^^^ p < 0.0001 between NPD control and NPD diabetic, ## p < 0.01 between NPD diabetic and LPD diabetic offspring. (j) Glomerulosclerotic index at 24 weeks of age in control and diabetic NPD and LPD offspring, data analyzed by three‐way ANOVA for diet, sex, and treatment, no sex difference was identified, data were consolidated and analyzed by 2‐way ANOVA for diet and treatment with values presented as mean ± SD, where *** p < 0.001 and **** p < 0.0001 following multiple comparisons. (k) Linear regression of the relationship between podocyte density and glomerulosclerotic index at 24 weeks of age (18 weeks of hyperglycemia in diabetic animals). In a–k: NPD—control (white circles), LPD—control (black circles), NPD—diabetic (white squares), LPD—diabetic (black squares). C, control; d, diabetic; M, male; f, female.

Article Snippet: Creatinine was measured using the Jaffe’ reaction of alkaline picrate with creatinine (Exocell).

Techniques: Control